Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by mercedesmanon May 22, 2024 9:10am
128 Views
Post# 36051607

RE:RE:RE:RE:The BS pumpers have returned, which is not good news

RE:RE:RE:RE:The BS pumpers have returned, which is not good news

Lol

Thats what I thought. 


He plays the " wounded creature" well. 

I have never seen any counter argument to good points or any intelligent, sound reasoning for that matter. Always about the past, never the future. 

This game of seeking an FDA  approval via RCTs is fraught with delays, roadblocks and likely politics and dare I say unseemliness. He probably should never have invested in the first place. You have to expect setbacks while hunting the big game. When you finally land one, the rewards can be enormous. 

MM 

<< Previous
Bullboard Posts
Next >>